Hematology CME

  • FREE

    CME Zone

    CME Zone offers various courses in many specialties offering CME Credits. The courses are quick and easy to complete.

    Target Audiences: General Surgeons, Oncologists, Various Specialties

    See full details chevron_right
    • Cost: Free
    • Credit hours: Varies depending on course
    • CME credits awarded by: Various Sponsors
    • Format: On-Demand Online
  • FREE

    Imedex eLearning Center

    Only the webcasts offer CME credit. Of these, 13 are in Oncology; other areas are Hematology (7) and Gastroenterology (6). Many of the webcasts offer multiple modules.

    Target Audiences:
    Physicians specializing in Hematology, Oncology, or Gastroenterology.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 131
    • CME credits awarded by: Imedex, Inc.
    • Format: On-Demand Online, Online Video, Online Audio
  • FREE

    Medscape Hematology-Oncology

    CME activities of special interest to hematologists and oncologists. Medscape contains a variety of educational formats:

    CONFERENCE COVERAGE – Reports of advances presented at major medical conferences; typically includes several tracks with news stories, expert interviews, and in-depth topic overviews.

    CLINICAL UPDATE – Comprehensive original review article on scientific advances in a clinical topic.

    FAST TRACK CLINICAL UPDATE – Narrowly focused original review article on scientific advances in a clinical topic.

    CME-LIVE – Real-time online events with streaming video, synchronized visuals, and interactive questions and answers; archived for 1 year.

    CLINICAL BRIEFS – Daily reports of major current medical research articles; 0.25 credits each

    JOURNAL CME – Articles selected from a wide selection of peer-reviewed journals.
    SPECIAL REPORT CME – Topic-based monthly email newsletter distributed to Medscape’s professional member database by specialty.

    INTERACTIVE PATIENT CASES – Original CME activity presented to the physician in an interactive, clinical case-based format. (See especially eMedicine CME Case Presentations.)
    CME CIRCLE – Multimedia content certified by other accredited professional education providers, typically from live symposia or monographs, and then posted on Medscape and archived for one year.

    Target Audience: Hematologists and Oncologists

    See full details chevron_right
    • Cost: Free
    • Credit hours: Varies depending on course
    • CME credits awarded by: Medscape and many other sponsoring organizations
    • Format: On-Demand Online
    • Material last updated: Continuously Updated
  • FREE

    Northwestern University: Feinberg School of Medicine: Office of Continuing Medical Education: Distance Learning

    The Northwestern University Feinberg School of Medicine offers various up to date CME activities that offer CME credits.

    Topics include:
    Neuro-oncology, Cardiovascular Health, Echocardiographic Assessment, and many more.

    Target Audience: Various Specialties

    See full details chevron_right
    • Cost: Varies depending on course
    • Credit hours: Varies depending on course
    • CME credits awarded by: Northwestern University Feinberg School of Medicine.
    • Format: Live Course, On-Demand Online
  • Oncology for Practicing Physicians

    The Oncology for Practicing Physicians course is:
    • Comprehensive, modularized, interactive, asynchronous and online, with the flexibility to select all or some modules
    • Designed, developed, and authored by expert McGill clinicians under the direction of a McGill scientific committee
    • Accredited for family physicians Mainpro-M 1 and specialists MOC Section 2 credits
    • Based on comprehensive needs assessments
    • Supportive of self-directed learning
    • Accessible from a variety of electronic devices, including smartphones and tablets
    • Providing access to oncology experts through the Ask the Expert feature

    Target Audiences:
    family physicians, specialists, trainees, medical students, nurses, and other healthcare professionals.

    See full details chevron_right
    • Cost: Varies depending on course
    • Credit hours: 1.5 per course
    • CME credits awarded by: Continuing Professional Development (CPD) McGill University.
    • Format: On-Demand Online
  • FREE

    Society for Translational Oncology

    Over 125 text-only courses in a comprehensive variety of hematology and oncology areas. Some recent topics are:
    • Comparative Effectiveness Research in Oncology
    • Oncology Comparative Effectiveness Research: A Multi-Stakeholder Perspective on Principles for Conduct and Reporting
    • Progress in the biological understanding and management of breast cancer associated CNS metastases
    • Multicenter Italian Experience in Liver Transplantation for Hepatocellular Carcinoma in HIV Infected Patients
    • Prospective Head and Neck Cancer Research: a Four-Decade Bibliometric Perspective
    • Role of Postoperative Vitamin D and/or Calcium Routine Supplementation in Preventing Hypocalcemia After Thyroidectomy

    Target Audiences: Hematologists, Oncologists

    See full details chevron_right
    • Cost: Free
    • Credit hours: Varies depending on course (Most are 1 or less)
    • CME credits awarded by: Society for Translational Oncology
    • Format: On-Demand Online
  • FREE

    OptumHealth Education Oncology

    There are many Oncology courses on this site offering between .75 – 1 CME credits.

    Topics covered include:
    Cancer Pain Management, Hodgkins Lymphoma, Cancer Immunotherapy, and many more.

    Target Audience: Hematologists, Oncologists

    See full details chevron_right
    • Cost: Free
    • Credit hours: 0.75 - 1 per course
    • CME credits awarded by: Various Sponsors
    • Format: On-Demand Online
  • FREE

    Multiple Myeloma (MM): Updates from 23rd Annual Congress of EHA (EHA 2018)

    Multiple myeloma (MM) is a hematologic malignancy of the lymphocytes. All cases are marked by monoclonal gammopathy, and while the true cause is unknown, associated factors are thought to include: radiation, genetics, viral infections, and the human immunodeficiency virus.

    After completing Multiple Myeloma (MM): Updates from 23rd Annual Congress of EHA (EHA 2018) physicians will better be able to:

    • Summarize the most impactful findings presented at EHA 2018 meeting relating to initial treatment of transplant eligible and ineligible myeloma
    • Summarize the most impactful findings presented at EHA 2018 meeting relating to role of autologous stem cell transplant
    • Summarize the most impactful findings presented at EHA 2018 meeting relating to current role of monoclonal antibodies
    • Summarize the most impactful findings presented at EHA 2018 meeting relating to novel immune therapies

    Target Audience: hematologists and oncologists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in oncology; and any other healthcare professionals with an interest in or who clinically encounter patients with MM.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 0.75
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: April 15, 2019
    • Expiration of CME credit: April 15, 2021
  • FREE

    Congenital Thrombotic Thrombocytopenic Purpura (cTTP) (Upshaw-Schulman syndrome): Therapeutic Updates, Best Practices, and Emerging Therapies

    Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder that impacts three in a million adults per year, with congenital or hereditary TTP (cTTP, also known as Upshaw-Schulman syndrome) accounting for a third of the overall incidence. The incidence of TTP rises with increasing age and the mortality rate of untreated TTP may be as high as 90%.

    After reviewing Congenital Thrombotic Thrombocytopenic Purpura (cTTP) (Upshaw-Schulman syndrome): Therapeutic Updates, Best Practices, and Emerging Therapies physiicians will be able to:

    • Describe the pathophysiology of cTTP such that it might inform treatment mechanisms.
    • Identify diagnostic criteria and differential diagnoses for cTTP
    • Describe current treatment standards for the management of cTTP and apply them to patient cases
    • Describe new and emerging therapies for the treatment of cTTP and the existing literature support its use in practice
    • Evaluate the likelihood cTTP in a patient case and develop a treatment plan

    Target Audience: hematologists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in hematology; and any other healthcare professionals with an interest in or who clinically encounter patients with cTTP.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: October 02, 2018
    • Expiration of CME credit: October 02, 2020
  • FREE

    CME: Cold agglutinin disease (CAD): Updates from the American Society of Hematology (ASH) 2019 annual meeting

    Cold agglutinin disease (CAD) is a subtype of autoimmune hemolytic anemia (AIHA) and characterized by cold agglutinin (CA) autoantibodies that cause the erythrocytic hemolysis. Also known as primary or idiopathic CAD, it is distinguished further from cold agglutinin syndrome (CAS), which is a complication of known conditions such as malignancy, infection, or autoimmune disease. Little is known about the epidemiology of CAD; one small study estimated incidence of 1 per 1 million people and prevalence of 1 per 16 million people with females twice as likely males to develop the disease and a median age of onset of 67 years.

    By the end of the session the participant will be able to:

    • Describe the pathogenesis and symptomology of AIHA generally and CAD specifically
    • Describe how diagnosis of CAD is distinguished from other subtypes of AIHA and challenges to successful identification of patients
    • Describe present and emerging treatment options for CAD and monitoring parameters for effectiveness of treatment
    • Develop a safe and clinically effective treatment plan including non-pharmacologic and pharmacologic therapy for patients with CAD

    Target Audience:

    The following healthcare professionals (HCPs): hematologists, oncologists, immunologists; physician assistants, nurse practitioners, and pharmacists who practice in the aforementioned areas of specialty; and any other HCPs with an interest in or who clinically encounter patients with CAD.

    See full details chevron_right
    • Cost: Free
    • Credit hours: 1
    • CME credits awarded by: ScientiaCME
    • Format: On-Demand Online
    • Material last updated: 2/21/2020
    • Expiration of CME credit: 2/21/2021